Credit Suisse Starts Genomic Health Inc. (GHDX) at Outperform
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 11
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 11
Join SI Premium – FREE
Credit Suisse initiates coverage on Genomic Health Inc. (NASDAQ: GHDX) with a Outperform. PT $43.00.
For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $34.98 yesterday.
For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $34.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clear Street Starts MasterCard (MA) at Buy
- Motilal Oswal Securities Starts Unimech Aerospace (UNIMECH:IN) at Buy
- JPMorgan Starts Mid-America Apartment Communities (MAA) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
